Moneycontrol PRO
you are here: HomeNewsBiocon
business
Jump to
52 Results Found
  • NPPA's move to positively impact insulin sales: Biocon Mar 17, 2011 05:10 PM IST

    NPPA's move to positively impact insulin sales: Biocon

    Speaking to CNBC-TV18, Kiran Mazumdar Shaw, chairman and ,managing director of Biocon said," I am glad that NPPA has given us this price increase. It still puts us at a discount to other multinationals and importers of insulin but at least one step at a time."

  • Clinigene & Syngene may list in a year's time: Biocon Jan 03, 2011 10:59 AM IST

    Clinigene & Syngene may list in a year's time: Biocon

    In an exclusive interview with CNBC-TV 18, Kiran Mazumdar Shaw, CMD of Biocon says that Clingene & Syngene to undergo transformation in the business model and would wait for a year before listing the IPO. She also expects Pfizer revenues in the next 24-36 months.

Sections
ISO 27001 - BSI Assurance Mark